Vitronectin in atherosclerotic disease

Ekmekci O., Ekmekci H.

CLINICA CHIMICA ACTA, cilt.368, ss.77-83, 2006 (SCI-Expanded, Scopus) identifier identifier identifier

  • Yayın Türü: Makale / Derleme
  • Cilt numarası: 368
  • Basım Tarihi: 2006
  • Doi Numarası: 10.1016/j.cca.2005.12.015
  • Dergi Adı: CLINICA CHIMICA ACTA
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.77-83
  • Anahtar Kelimeler: vitronectin, atherosclerosis, thrombosis, coronary artery disease, PLASMINOGEN-ACTIVATOR INHIBITOR-1, S-PROTEIN VITRONECTIN, SMOOTH-MUSCLE-CELLS, NEOINTIMA FORMATION, PLATELET-ADHESION, IMMUNOHISTOCHEMICAL LOCALIZATION, PLASMA VITRONECTIN, BINDING-PROTEIN, VASCULAR INJURY, IDENTIFICATION
  • İstanbul Üniversitesi-Cerrahpaşa Adresli: Evet

Özet

Atherosclerosis is characterized by the development of an intimal thickening that contains monocytes, T lymphocytes, and smooth muscle cells within an accumulation of lipid and extracellular matrix proteins. Vitronectin is a plasma glycoprotein implicated as a regulator of diverse physiological process, including blood coagulation, fibrinolysis, pericellular proteolysis, complement dependent immune responses, and cell attachment and spreading. Because of its ability to bind platelet glycoproteins and mediate platelet adhesion and aggregation at sites of vascular injury, vitronectin has become an important mediator in the pathogenesis of coronary atherosclerosis. (c) 2005 Elsevier B.V. All rights reserved.